Solventum Corporation·Healthcare

SOLV Energy is undervalued, with a recurring O&M revenue stream and a robust $8B backlog supporting near-term growth. MWH's installed base and long-term O&M contracts create a higher-quality, stickier earnings profile than typical EPC contractors. Scale advantages position MWH to capture larger, more complex projects and adjacent revenue streams, widening its competitive moat.

ST. PAUL, Minn., April 14, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its first quarter fiscal 2026 financial results on Tuesday, May 5, 2026, after the U.S. financial markets close.

Solventum (SOLV) is rated Very Unattractive due to negative economic earnings, low ROIC (5%), and an expensive valuation. Street Earnings and significantly overstate SOLV's true profitability; Core Earnings provide a more accurate measure. Solventum's 1Q26 Street EPS estimate is overstated by $0.78/share (58%), with Core EPS at $0.57 versus Street EPS at $1.35.

Investors looking for stocks in the Medical Services sector might want to consider either Solventum (SOLV) or HealthEquity (HQY). But which of these two stocks is more attractive to value investors?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Solventum has a few good businesses, but the market is treating it as a complicated company. Its main parts are MedSurg, Dental, HIS, and a smaller Water / All Other. The thesis says the stock looks much cheaper than the value of the parts. The business could be worth about $166.6 per share based on SOTP analysis. The main idea is to keep MedSurg as the core business and see more value in the other parts on their own.
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Healthcare
Medical - Care Facilities
22,000
2024-04-01
0.77